Pulmonx Corp

Pulmonx Corp

World Rank (Jan-05-2024)
13,117
Market Cap (Jan-05-2024)
0.460 Billion USD
World Rank (Jul-30-2023)
12,667
Market Cap (Jul-30-2023)
0.507 Billion USD
World Rank (Jan-07-2022)
8,859
Market Cap (Jan-07-2022)
1.114 Billion USD
World Rank (Jan-01-2021)
4,854
Market Cap (Jan-01-2021)
2.462 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
LUNG
Market Cap (Mar-08-2026)
0.08
Employee Count
202
Employee Count as of Date
As on 2020
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
54 Million USD
Annual Operating Income in USD
-59 Million USD
Annual Net Income in USD
-59 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Total Assets in USD
193 Million USD
Total Liabilities in USD
40 Million USD
Total Equity in USD
154 Million USD
Balance Sheet for Period Ending
Dec-2022 ending year
Business Sector
Healthcare
Medical Equipment / Instruments
Company Website
PULMONX CORP
Yahoo
Yahoo @ Nasdaq
Company Profile
Pulmonx Pulmonx Corporation is a global leader in interventional pulmonology, planning tools and treatments for obstructive lung disease company. The company annual revenue is 42.4 million USD and 202 employees as on 2020. The headquarters is in USA.
IPO Year
2020
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Industrial Specialties

Share